Organization
Sunshine Lake Pharma
30 clinical trials
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Orally Administered HEC96719 Tablets in Adult Patients With Presumed Non-Cirrhotic Non-Alcoholic SteatohepatitisStatus: Completed, Estimated PCD: 2023-09-05
Clinical trial
Single Dose Absorption, Distribution, Metabolism, and Excretion Study of [14C] Yiqibuvir in Healthy Male ParticipantsStatus: Completed, Estimated PCD: 2023-09-12
Clinical trial
HEC73543 Versus Salvage Chemotherapy in Relapsed or Refractory FLT3-ITD Acute Myeloid Leukemia: a Multicenter, Open-label, Randomized Phase 3 TrialStatus: Recruiting, Estimated PCD: 2026-02-10
Clinical trial
A Study In Healthy Subjects To Assess The Effects Of Rifampicin Capsules and Probenecid Tablets On The Pharmacokinetic Profile Of Rongliflozin CapsulesStatus: Completed, Estimated PCD: 2022-07-22
Clinical trial
A Phase II Study of the Ningetinib in Advanced NSCLC With MET Exon 14 Skipping MutationsStatus: Not yet recruiting, Estimated PCD: 2024-09-09
Clinical trial
A Multi-center, Randomized, Open, Phase III Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared Efficacy and Safety With Insulin Degludec/Insulin Aspart(Ryzodeg) in Chinese Subjects With Type 2 DiabetesStatus: Not yet recruiting, Estimated PCD: 2023-12-01
Clinical trial
To Evaluate the Pharmacokinetics and Safety of Yimitasvir Phosphate Capsules in Subjects With Moderate and Severe Liver Function Impairment and Healthy Subjects in a Single-center, Non-randomized, Open, Single-dose AdministrationStatus: Completed, Estimated PCD: 2022-06-09
Clinical trial
A Single-center, Open, Self-controlled Design Clinical Study to Evaluate the Pharmacokinetic Effects of Rifampicin or Itraconazole on Single-dose Laolotinib Mesylate Capsules in Healthy SubjectsStatus: Active (not recruiting), Estimated PCD: 2023-01-21
Clinical trial
A Single-center, Non-randomized, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and End-stage Renal Disease Without HemodialysisStatus: Completed, Estimated PCD: 2022-05-07
Clinical trial
Phase 1/2 Study of the Highly-selective RET Inhibitor,HEC169096 in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2025-07-30
Clinical trial
A Phase II, Multi-center, Randomized, Placebo-controlled (Double-blind Design), Active Comparator-controlled (Open-label Design), Parallel-group, Dose-finding Study, to Evaluate the Efficacy and Safety of HEC585 Tablets in Patients With IPFStatus: Recruiting, Estimated PCD: 2024-05-10
Clinical trial
A Phase IIb, Multi-center, Randomized, Double Blinded, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of HEC585 Tablets in Patients With Progressive Fibrosing Interstitial Lung DiseaseStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Single Dose Absorption, Distribution, Metabolism, and Excretion Study of [14C] Antaitavir Hasophate in Healthy Male ParticipantsStatus: Completed, Estimated PCD: 2023-01-02
Clinical trial
A Phase Ib, Multi-center, Open-label Study of Z650 in Advanced Esophageal Squamous Cell Carcinoma (ECSS) With Epidermal Growth Factor Receptor (EGFR) Over Expression or Gene AmplificationStatus: Completed, Estimated PCD: 2022-12-13
Clinical trial
A Single-center, Open-label Study to Investigate the Effect of a Single Oral Dose of HEC74647 and HEC110114 on the Pharmacokinetics of Midazolam, and Their Metabolites in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-12-13
Clinical trial
A Pharmacokinetic Study of Larotinib in Subjects With Mild/Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic FunctionStatus: Not yet recruiting, Estimated PCD: 2024-12-30
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study of Ascending Single and Multiple Doses to Evaluate the Safety, Tolerability, PK, PDand Randomized, Open-label，Crossover, Food Effect Study of HEC93077 in Healthy Chinese Subjects and Hyperuricemia PatientsStatus: Recruiting, Estimated PCD: 2023-10-25
Clinical trial
Single Dose Absorption, Distribution, Metabolism, and Excretion Study of [14C] - Larotinib in Healthy Male ParticipantsStatus: Completed, Estimated PCD: 2022-01-10
Clinical trial
Clinical Trial of Absorption, Metabolism and Excretion of [14C]-HEC585 in Chinese Adult Male Healthy SubjectsStatus: Completed, Estimated PCD: 2022-08-14
Clinical trial
A Single Center, Randomized, Double-Blind, Placebo-Controlled Study of Single/Multiple Ascending Doses to Evaluate the Safety, Tolerability, Pharmacokinetics, and Single Center, Randomized, Double-Blind, Two Periods, Crossover, Food Effect Study of HEC122505MsOH Tablets in Healthy Chinese SubjectsStatus: Completed, Estimated PCD: 2022-01-06
Clinical trial
A Phase 1, Double-blind, Randomized, Placebo-controlled, Dose-escalation, Pharmacokinetic Study of Single and Multiple Oral Dosing of HEC53856, A Novel HIF-PHD Inhibitor, in Healthy Non-elderly Volunteers.Status: Completed, Estimated PCD: 2020-01-01
Clinical trial
A Phase 1, Randomized, Double-blind, Placebo-controlled, Single- and Multiple-dose Study in Healthy Subjects and Chronic Hepatitis B Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of FreethiadineStatus: Completed, Estimated PCD: 2023-01-17
Clinical trial
A Food Effect Phase I Study of the Clifutinib in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-12-08
Clinical trial
Pharmacokinetics, Pharmacodynamic, Safety and Immunogenicity Characteristics of Insulin Degludec Injection (RD15003) and Insulin Degludec Injection ( Tresiba®）in Healthy Subjects: a Phase I Single-center, Randomized, Open-label, Single-dose, Cross-over Clinical StudyStatus: Completed, Estimated PCD: 2022-03-21
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study of Ascending Single and Multiple Doses to Evaluate the Safety, Tolerability, Pharmacokinetics/Pharmacodynamics, and Randomized, Open-label, Food Effect Study of HEC73077 in Healthy SubjectsStatus: Completed, Estimated PCD: 2023-01-04
Clinical trial
A Phase Ⅱ/Ⅲ Study to Evaluate Efficacy and Safety of Antaitavir Hasophate Capsules in Combination With Yiqibuvir Tablets in Adult Subject With Chronic HCV InfectionStatus: , Estimated PCD: 2023-04-22
Clinical trial
A Single-center, Randomized, Double-blind, Single and Multiple Dosing, Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of StudyStatus: , Estimated PCD: 2023-12-30
Clinical trial
Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Combination With Entecavir in Comparison With Entecavir Alone in Patients With Chronic HBV Who Are HBeAg PositiveStatus: Recruiting, Estimated PCD: 2023-05-30
Clinical trial
A Single-Center, Randomized, Double-Blind, Single and Multiple Doses, Placebo-Controlled Study,To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, Food Effects of HEC116094HCl•3H2O and the Interaction With Oseltamivir Phosphate Capsules in Chinese Healthy SubjectsStatus: Completed, Estimated PCD: 2022-10-02
Clinical trial
Single Dose Absorption, Distribution, Metabolism, and Excretion Study of [14C]- Rongliflozin in Healthy Male ParticipantsStatus: Completed, Estimated PCD: 2021-12-31